Company intelligence / Profile preview

Formation Nation

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Formation Bio advances acquired or in-licensed assets using proprietary AI-driven platforms, with ongoing Phase 2/3 trials and at least one recent out-licensing deal valued up to €545M in milestones for an autoimmune disease program. Clinical results indicate faster trial conduct versus industry standard, but detailed clinical efficacy/safety summaries for each asset are not published.

Therapeutic areas: ImmunologyRheumatologyDermatology
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

SanofiOpenAI

Beyond the preview

Go deeper on Formation Nation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Formation Nation.

Explore the full profile